BSX · News · 20260914N

Acquisition / Partnership / Divestiture

BOSTON SCIENTIFIC CORP · 2026-09-14 · Importance 24 · Surprise 24

Boston Scientific is using acquisitions to expand into high-growth markets, according to the report. Penumbra is identified as adding a major thrombectomy opportunity to Boston Scientific’s growth strategy. The digest provides no transaction value, closing date, or expected revenue contribution for the Penumbra opportunity.

Key facts

• Penumbra is adding a major thrombectomy opportunity to BOSTON SCIENTIFIC CORP's portfolio/reach. source
• BOSTON SCIENTIFIC CORP has a "deal-making push" that expands its reach into high-growth markets. source